Merck KGaA ADR
USUSDMerck KGaA ADR (MI:1MRKX) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 6. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.
- Merck KGaA — MRK · XETRA DE Registrska številka ni znana
O Podjetju
- Spletna Stran
- merck.com
- Odnosi z Vlagatelji
- merck.com/investor-relations/
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sedež
- RAHWAY, Germany
- Izvršni Direktor
- Kai Beckmann
- Zaposleni
- 62 136
- Na Borzi od
- 22.11.2023 (MI:1MRKX)
- Delnice v Obtoku
- 2.47 mrd. na dan 2026-07-31
- Prosto Prenosljive Delnice
- 644.35 mio.
- Tržna Kapitalizacija
- 67.93 mrd. USD
- Notranje Osebe
- 0%
- Institucionalni Vlagatelji
- 0.02%
- Panoga (SIC)
- Pharmaceutical Preparations
- Pravna Oblika
- XSNP
- ISIN
- US58933Y1055
- LEI
- 4YV9Y5M8S0BRK1RP0397
- Delež Izplačila
- 262%
- FCF
- 16.1 mrd. USD52%
- Dolg
- 51.1 mrd. USD2.8 let FCF
- Dividendni Staž
- 56+ let
- Dobički, FCF in izplačane dividende — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
Opis
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.
Borze in Oznake
| Borza | Oznaka | Valuta | Cena | Vrsta |
|---|---|---|---|---|
| US USA Stocks | MRK dodatna | USD | 145.6 +2.26% | navadne delnice |
| LSE London Stock Exchange | 0QAH IOB | USD | 148.65 -0.12% | navadne delnice |
| MI Borsa Italiana (Milan) | 1MRKX glavna | EUR | 129.86 +0.23% | navadne delnice |
| MX Mexican Stock Exchange | MRK dodatna | MXN | 2 690 +6.68% | navadne delnice |
| VI Vienna Stock Exchange | MRK dodatna | EUR | 124.84 -2.79% | navadne delnice |
| XETRA Xetra | 6MK dodatna | EUR | 129.78 +0.09% | navadne delnice |
Dividende
Merck KGaA ADR (1MRKX) izplačuje dividende četrtletno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 3.0202 EUR na delnico (plačila: 4). To je približno 2.33% trenutne cene delnice. Glede na zgodovino izplačil se naslednji datum ex-dividende pričakuje okoli 15.12.2026. Leta neprekinjenih dividend: 56.
| Ex-Datum | Izplačilo | Znesek | % | Vrsta | Oznaka |
|---|---|---|---|---|---|
| 2026-09-15 | — | 0.7551 EUR | 0.6/2.3 % | četrtletno | MI:1MRKX |
| 2026-06-15 | — | 0.7551 EUR | 0.6/2.3 % | četrtletno | MI:1MRKX |
| 2026-03-16 | — | 0.7551 EUR | 0.6/2.3 % | četrtletno | MI:1MRKX |
| 2025-12-15 | — | 0.7551 EUR | 0.6/2.2 % | četrtletno | MI:1MRKX |
| 2025-09-15 | — | 0.7195 EUR | 0.6/2.2 % | četrtletno | MI:1MRKX |
| 2025-06-16 | — | 0.7195 EUR | 0.6/2.2 % | četrtletno | MI:1MRKX |
| 2025-03-17 | — | 0.7195 EUR | 0.6/2.2 % | četrtletno | MI:1MRKX |
| 2024-12-16 | — | 0.7195 EUR | 0.6/2.1 % | četrtletno | MI:1MRKX |
| 2024-09-16 | — | 0.6840 EUR | 0.5/2.1 % | četrtletno | MI:1MRKX |
| 2024-06-17 | — | 0.6840 EUR | 0.5/1.6 % | četrtletno | MI:1MRKX |
| 2024-03-14 | — | 0.6840 EUR | 0.5/1.1 % | četrtletno | MI:1MRKX |
| 2023-12-14 | — | 0.6840 EUR | 0.5/0.5 % | četrtletno | MI:1MRKX |
Največji Imetniki
| Imetnik | Delež | Delnice | Datum Poročila |
|---|---|---|---|
| BlackRock | 9.2% | 227 mio. | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 161.32 mio. | 2026-06-30 |
| State Street Corporation | 4.88% | 120.41 mio. | 2026-06-30 |
| Wellington Management Gr… | 3.5% | 86.25 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 78.41 mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.75% | 67.74 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 64 mio. | 2026-06-30 |
| Geode Capital Management… | 2.46% | 60.74 mio. | 2026-06-30 |
| Charles Schwab Investmen… | 2.2% | 54.37 mio. | 2026-06-30 |
| Morgan Stanley | 1.97% | 48.64 mio. | 2026-06-30 |
| FMR, LLC | 1.84% | 45.44 mio. | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.78% | 43.89 mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.33% | 32.89 mio. | 2026-08-31 |
| Fidelity Concord Street… | 1.29% | 31.94 mio. | 2026-07-31 |
| SCHWAB STRATEGIC TRUST-S… | 1.25% | 30.86 mio. | 2026-05-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.22% | 30.22 mio. | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 0.95% | 23.51 mio. | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 17.75 mio. | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.65% | 15.95 mio. | 2026-07-31 |
| VANGUARD SPECIALIZED FUN… | 0.57% | 13.97 mio. | 2026-07-31 |
| DAVIS ROBERT M (Chief Ex… | ≈0.02% | 450 351 | 2026-04-29 |
| CHATTOPADHYAY SANAT (Off… | ≈0.01% | 200 675 | 2026-04-29 |
| DELUCA RICHARD ROBERT JR… | ≈0% | 110 167 | 2026-08-12 |
| LI DEAN Y (Officer) | ≈0% | 94 431 | 2026-04-29 |
| LITCHFIELD CAROLINE (Chi… | ≈0% | 92 300 | 2026-04-29 |
| ZACHARY JENNIFER L (Gene… | ≈0% | 45 509 | 2026-08-12 |
| GUINDO CHIRFI (Officer) | ≈0% | 36 613 | 2026-08-13 |
| WILLIAMS DAVID MICHAEL (… | ≈0% | 31 716 | 2026-08-05 |
| ROMANELLI JOSEPH EDWARD… | ≈0% | 28 739 | 2026-01-26 |
| OOSTHUIZEN JOHANNES JACO… | ≈0% | 21 895 | 2026-04-29 |
| Trust for Professional M… | 0% | 24 803 | 2026-05-31 |
| Rhumbline Advisers | 0% | 10 919 | 2026-06-30 |
| SP Funds Trust-SP Funds… | 0% | 6 542 | 2026-07-31 |
| Atlas Capital Advisors I… | 0% | 2 467 | 2026-06-30 |
| Gamma Investing LLC | 0% | 2 302 | 2026-06-30 |
| Salomon & Ludwin, LLC | 0% | 356 | 2026-06-30 |
| PNC Financial Services G… | 0% | 2 | 2026-06-30 |
| The Vanguard Group | — | — | — |
